9Zhao JL, Yang YJ, Gao RL. Pretreatment with simvastatin reduces myocardial no-reflow by opening mitochondrial KATP channel. Br J Pharmaeol, 2006, 149:243 - 249. 被引量：1
10Bell RM, Yellon DM. Atorvastatin, administered at heonset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway. JACC, 2003, 41:508 - 515. 被引量：1
二级参考文献22
1Cai H, Harrison D G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res, 2000,87:840～844. 被引量：1
2Berry C, Humilton C A, Brosonan M J, et al. Investigation into the sources of superoxide production in human internal mammary arteries. Circulation, 2000,101:2206～2212. 被引量：1
3Munzel T, Kurz S, Thoenes, et al. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase: a new action for an old drug. J Clin Invest, 1996,98:1465～1470. 被引量：1
4Hamilton C A, Brosnan M J. Superoxide excess in hypertension and aging:a common cause of endothelial dysfunction. Hypertension, 2001,37(2 pt 2):529～534. 被引量：1
5Kerr S, Brosnan M J, Mclntyre M, et al. Superoxide anion production is increased in a model of genetic hypertension: the role of the endothlium. Hypertens, 1999,33:1353～1358. 被引量：1
6Zalba G, Beaumont F J, José F J, et al. Vascular NADH/NADPH is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension, 2000,35:1055～1061. 被引量：1
7Stepp DW, Ou J, Ackerman AW, et al. Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ. Am J Physiol Heart Circ Physiol,2002 ;283 :H750-759. 被引量：1
8Ou J,Ou Z,Jones DW,et al. L-4F,an apolipoprotein A-1 mimetic,dramatically improves vasodilation in hypercholestemlemia and sickle cell disease. Circulation ,2003,107:2337-2341. 被引量：1
9Mason RP,Walter MF,Jacob RF. Effects of HMG-CoA reductase inhibitors on endothelial function : role of microdomains and oxidative stress.Circulation,2004,109 ( Suppl 1 ) : Ⅱ34-41. 被引量：1
10Wassmann S, Laufs U, Stamenkovic D, et al. Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Circulation,2002,105:2053-2091. 被引量：1
